HK1255201A1 - Methods of producing two chain proteins in bacteria - Google Patents

Methods of producing two chain proteins in bacteria

Info

Publication number
HK1255201A1
HK1255201A1 HK18114324.8A HK18114324A HK1255201A1 HK 1255201 A1 HK1255201 A1 HK 1255201A1 HK 18114324 A HK18114324 A HK 18114324A HK 1255201 A1 HK1255201 A1 HK 1255201A1
Authority
HK
Hong Kong
Prior art keywords
bacteria
producing
methods
chain proteins
proteins
Prior art date
Application number
HK18114324.8A
Other languages
Chinese (zh)
Inventor
James Giulianotti
Dorothea Reilly
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1255201A1 publication Critical patent/HK1255201A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
HK18114324.8A 2014-11-05 2018-11-08 Methods of producing two chain proteins in bacteria HK1255201A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462075792P 2014-11-05 2014-11-05
US201562207882P 2015-08-20 2015-08-20
PCT/US2015/059339 WO2016073791A1 (en) 2014-11-05 2015-11-05 Methods of producing two chain proteins in bacteria

Publications (1)

Publication Number Publication Date
HK1255201A1 true HK1255201A1 (en) 2019-08-09

Family

ID=54754738

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18114324.8A HK1255201A1 (en) 2014-11-05 2018-11-08 Methods of producing two chain proteins in bacteria

Country Status (13)

Country Link
US (2) US10112994B2 (en)
EP (1) EP3215526A1 (en)
JP (3) JP6875276B2 (en)
KR (1) KR20170075793A (en)
CN (1) CN108064308B (en)
AU (1) AU2015342961B2 (en)
BR (1) BR112017009152A2 (en)
CA (1) CA2966558C (en)
HK (1) HK1255201A1 (en)
IL (1) IL252027B (en)
MX (1) MX2017005930A (en)
RU (1) RU2705274C2 (en)
WO (1) WO2016073791A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2966558C (en) 2014-11-05 2024-03-12 Genentech, Inc. Methods of producing two chain proteins in bacteria
RU2020141422A (en) 2014-11-05 2021-01-13 Дженентек, Инк. METHODS FOR OBTAINING TWO-STRAIN PROTEINS IN BACTERIA
AU2019375413A1 (en) 2018-11-05 2021-05-27 Genentech, Inc. Methods of producing two chain proteins in prokaryotic host cells
EP3914615A1 (en) * 2019-01-23 2021-12-01 F. Hoffmann-La Roche AG Methods of producing multimeric proteins in eukaryotic host cells

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE266710C (en)
FR2413974A1 (en) 1978-01-06 1979-08-03 David Bernard DRYER FOR SCREEN-PRINTED SHEETS
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DD266710A3 (en) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Process for the biotechnical production of alkaline phosphatase
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US6548640B1 (en) 1986-03-27 2003-04-15 Btg International Limited Altered antibodies
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
EP0307434B2 (en) 1987-03-18 1998-07-29 Scotgen Biopharmaceuticals, Inc. Altered antibodies
CA1338518C (en) 1987-09-23 1996-08-13 Joyce M. Zarling Antibody heteroconjugates for the killing of hiv-infected cells
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
KR0184860B1 (en) 1988-11-11 1999-04-01 메디칼 리써어치 카운실 Single domain ligands receptors comprising said ligands methods for their production and use of said ligands
DE3920358A1 (en) 1989-06-22 1991-01-17 Behringwerke Ag BISPECIFIC AND OLIGO-SPECIFIC, MONO- AND OLIGOVALENT ANTI-BODY CONSTRUCTS, THEIR PRODUCTION AND USE
DE69029036T2 (en) 1989-06-29 1997-05-22 Medarex Inc SPECIFIC REAGENTS FOR AIDS THERAPY
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
DE69120146T2 (en) 1990-01-12 1996-12-12 Cell Genesys Inc GENERATION OF XENOGENIC ANTIBODIES
US6075181A (en) 1990-01-12 2000-06-13 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
ES2246502T3 (en) 1990-08-29 2006-02-16 Genpharm International, Inc. TRANSGENIC NON-HUMAN ANIMALS ABLE TO PRODUCE HETEROLOGICAL ANTIBODIES.
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
ES2113940T3 (en) 1990-12-03 1998-05-16 Genentech Inc ENRICHMENT METHOD FOR PROTEIN VARIANTS WITH ALTERED UNION PROPERTIES.
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
EP0586505A1 (en) 1991-05-14 1994-03-16 Repligen Corporation Heteroconjugate antibodies for treatment of hiv infection
ES2206447T3 (en) 1991-06-14 2004-05-16 Genentech, Inc. HUMANIZED ANTIBODY FOR HEREGULINE.
GB9114948D0 (en) 1991-07-11 1991-08-28 Pfizer Ltd Process for preparing sertraline intermediates
US7018809B1 (en) 1991-09-19 2006-03-28 Genentech, Inc. Expression of functional antibody fragments
US5587458A (en) 1991-10-07 1996-12-24 Aronex Pharmaceuticals, Inc. Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
AU675929B2 (en) 1992-02-06 1997-02-27 Curis, Inc. Biosynthetic binding protein for cancer marker
ATE149570T1 (en) 1992-08-17 1997-03-15 Genentech Inc BISPECIFIC IMMUNOADHESINS
JPH08511420A (en) 1993-06-16 1996-12-03 セルテック・セラピューテイクス・リミテッド Body
US5789199A (en) 1994-11-03 1998-08-04 Genentech, Inc. Process for bacterial production of polypeptides
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5840523A (en) 1995-03-01 1998-11-24 Genetech, Inc. Methods and compositions for secretion of heterologous polypeptides
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5869046A (en) 1995-04-14 1999-02-09 Genentech, Inc. Altered polypeptides with increased half-life
ES2304786T3 (en) 1995-04-27 2008-10-16 Amgen Fremont Inc. ANTI-IL-8 HUMAN ANTIBODIES, DERIVED FROM IMMUNIZED XENORATONES.
EP0823941A4 (en) 1995-04-28 2001-09-19 Abgenix Inc Human antibodies derived from immunized xenomice
DK1500329T3 (en) 1996-12-03 2012-07-09 Amgen Fremont Inc Human antibodies that specifically bind TNF-alpha
US6610833B1 (en) 1997-11-24 2003-08-26 The Institute For Human Genetics And Biochemistry Monoclonal human natural antibodies
ATE531812T1 (en) 1997-12-05 2011-11-15 Scripps Research Inst HUMANIZATION OF RODENT ANTIBODIES
US6194551B1 (en) 1998-04-02 2001-02-27 Genentech, Inc. Polypeptide variants
ATE375365T1 (en) 1998-04-02 2007-10-15 Genentech Inc ANTIBODIES VARIANTS AND FRAGMENTS THEREOF
HUP0104865A3 (en) 1999-01-15 2004-07-28 Genentech Inc Polypeptide variants with altered effector function
US6737056B1 (en) 1999-01-15 2004-05-18 Genentech, Inc. Polypeptide variants with altered effector function
JP2002541073A (en) 1999-03-17 2002-12-03 メディカル リサーチ カウンシル Method for molecular refolding of Ig domain-containing polypeptide
GB9911569D0 (en) * 1999-05-18 1999-07-21 Oxford Biomedica Ltd Antibodies
AU784983B2 (en) 1999-12-15 2006-08-17 Genentech Inc. Shotgun scanning, a combinatorial method for mapping functional protein epitopes
ES2324645T3 (en) * 2000-11-03 2009-08-12 Genentech, Inc. CHANGES OF METABOLIC RATE IN FERMENTATIONS THAT EXPRESS RECOMBINANT PROTEINS.
WO2002061090A2 (en) * 2000-12-14 2002-08-08 Genentech, Inc. Prokaryotically produced antibodies and uses thereof
ATE382053T1 (en) 2001-08-27 2008-01-15 Genentech Inc SYSTEM FOR ANTIBODIES EXPRESSION AND SYNTHESIS
ATE290020T1 (en) 2001-08-31 2005-03-15 Avidex Ltd SOLUBLE T CELL RECEPTOR
EP1513879B1 (en) 2002-06-03 2018-08-22 Genentech, Inc. Synthetic antibody phage libraries
AU2003267999B2 (en) * 2002-07-19 2010-03-11 Abbvie Biotechnology Ltd Treatment of TNFalpha related disorders
US7361740B2 (en) 2002-10-15 2008-04-22 Pdl Biopharma, Inc. Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
DE60332957D1 (en) 2002-12-16 2010-07-22 Genentech Inc IMMUNOGLOBULIN VARIANTS AND ITS USES
AU2004205631A1 (en) 2003-01-16 2004-08-05 Genentech, Inc. Synthetic antibody phage libraries
US7635472B2 (en) 2003-05-31 2009-12-22 Micromet Ag Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders
SI1641822T1 (en) 2003-07-08 2013-08-30 Genentech, Inc. Il-17 a/f heterologous polypeptides and therapeutic uses thereof
DK1691833T3 (en) 2003-11-28 2010-05-03 Micromet Ag Compositions comprising polypeptides
US7235641B2 (en) 2003-12-22 2007-06-26 Micromet Ag Bispecific antibodies
JP4943161B2 (en) 2003-12-23 2012-05-30 ジェネンテック， インコーポレイテッド Treatment of cancer with a novel anti-IL13 monoclonal antibody
JP4501451B2 (en) 2004-02-18 2010-07-14 株式会社豊田自動織機 Coating composition, method for producing transparent protective film using coating composition, and organic glass having transparent protective film
MXPA06011199A (en) 2004-03-31 2007-04-16 Genentech Inc Humanized anti-tgf-beta antibodies.
US7785903B2 (en) 2004-04-09 2010-08-31 Genentech, Inc. Variable domain library and uses
CA2885854C (en) 2004-04-13 2017-02-21 F. Hoffmann-La Roche Ag Anti-p-selectin antibodies
CA2577082A1 (en) 2004-09-02 2006-03-16 Genentech, Inc. Heteromultimeric molecules
TWI380996B (en) 2004-09-17 2013-01-01 Hoffmann La Roche Anti-ox40l antibodies
AU2006301492B2 (en) 2005-10-11 2011-06-09 Amgen Research (Munich) Gmbh Compositions comprising cross-species-specific antibodies and uses thereof
ES2577292T3 (en) 2005-11-07 2016-07-14 Genentech, Inc. Binding polypeptides with diversified VH / VL hypervariable sequences and consensus
US20070237764A1 (en) 2005-12-02 2007-10-11 Genentech, Inc. Binding polypeptides with restricted diversity sequences
CA2651567A1 (en) 2006-05-09 2007-11-22 Genentech, Inc. Binding polypeptides with optimized scaffolds
LT2520590T (en) 2007-04-03 2018-09-10 Amgen Research (Munich) Gmbh Cross-species-specific binding domain
CN100592373C (en) 2007-05-25 2010-02-24 群康科技(深圳)有限公司 Liquid crystal panel drive device and its drive method
KR20110025649A (en) * 2008-05-05 2011-03-10 노비뮨 에스 에이 Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
RU2011148913A (en) 2009-05-01 2013-06-10 Эбботт Лэборетриз IMMUNOGLOBULIN WITH TWO VARIABLE DOMAINS AND ITS APPLICATION
RU2585488C2 (en) 2009-11-05 2016-05-27 Дженентек, Инк. Methods and composition for secretion of heterologous polypeptides
ES2617777T5 (en) 2010-04-23 2022-10-13 Hoffmann La Roche Production of heteromultimeric proteins
WO2012106615A1 (en) 2011-02-03 2012-08-09 Xoma Technology Ltd. Methods and materials for enhancing functional protein expression in bacteria
US9158890B2 (en) 2011-07-27 2015-10-13 At&T Mobility Ii Llc Mobile applications and methods for conveying performance information of a cardiac pacemaker
EP3418306B1 (en) * 2011-10-11 2023-12-06 F. Hoffmann-La Roche AG Improved assembly of bispecific antibodies
WO2014165771A2 (en) * 2013-04-05 2014-10-09 Genentech, Inc. Anti-il-4 antibodies and bispecific antibodies and uses thereof
SG11201508642WA (en) 2013-04-19 2015-11-27 Sutro Biopharma Inc Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones
BR112016018980A2 (en) * 2014-02-21 2017-10-10 Genentech Inc method of treating a disorder, multispecific antibody, isolated nucleic acid, host cell, methods of producing an antibody, producing an antibody half or multispecific antibody, and producing a multispecific, immunoconjugate antibody and pharmaceutical formulation
CA2966558C (en) 2014-11-05 2024-03-12 Genentech, Inc. Methods of producing two chain proteins in bacteria
RU2020141422A (en) * 2014-11-05 2021-01-13 Дженентек, Инк. METHODS FOR OBTAINING TWO-STRAIN PROTEINS IN BACTERIA

Also Published As

Publication number Publication date
JP2018500008A (en) 2018-01-11
RU2017119403A3 (en) 2019-03-27
CN108064308B (en) 2023-06-09
WO2016073791A1 (en) 2016-05-12
IL252027A0 (en) 2017-06-29
CA2966558A1 (en) 2016-05-12
CA2966558C (en) 2024-03-12
BR112017009152A2 (en) 2018-03-06
US11299539B2 (en) 2022-04-12
EP3215526A1 (en) 2017-09-13
MX2017005930A (en) 2017-06-30
RU2017119403A (en) 2018-12-05
JP2023088935A (en) 2023-06-27
AU2015342961B2 (en) 2021-08-12
IL252027B (en) 2021-10-31
RU2705274C2 (en) 2019-11-06
AU2015342961A1 (en) 2017-06-15
CN108064308A (en) 2018-05-22
JP6875276B2 (en) 2021-05-19
KR20170075793A (en) 2017-07-03
US20190112368A1 (en) 2019-04-18
US20160159898A1 (en) 2016-06-09
US10112994B2 (en) 2018-10-30
JP2021119777A (en) 2021-08-19

Similar Documents

Publication Publication Date Title
HK1244185A1 (en) Methods and compositions for egg white protein production
IL287373A (en) Methods of producing two chain proteins in bacteria
SG11201608605QA (en) Methods and means for enhancing rna production
HK1231400A1 (en) Selective reduction of proteins
IL252696B (en) Protein manufacture
GB2522923B (en) Insoles and production methods
IL246593A0 (en) Increased protein expression in plants
HK1255201A1 (en) Methods of producing two chain proteins in bacteria
HUE055515T2 (en) Bioactive protein, use thereof and method for its production
GB201401648D0 (en) Protein
IL250451A0 (en) Anti-vasa antibodies, and methods of production and use thereof
IL250275A0 (en) Semi-continuous culture methods
GB201411943D0 (en) Process and protein product
EP3154360C0 (en) Dairy products and methods for producing them
ZA201703336B (en) Novel products and methods
IL249638A0 (en) Methods of oil production in microorganisms
IL252712A0 (en) Method of protein manufacture
ZA201700867B (en) Modifying protein production in plants
PL3177727T3 (en) Dewatering methods in fermentation processes
GB201416858D0 (en) Methods of in Vitro Oocyte Development
EP3109243A4 (en) Gamma-butylolactone composition and production method therefor
TH1501005968A (en) Protein components and production methods
HUE042862T2 (en) Dewatering methods in fermentation processes
GB201419239D0 (en) Methods and apparatus relating to injection-moulded objects
GB201414371D0 (en) Protein modification